Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression data from Parkison's iPSCs with four copies of SNCA, and equivalent cell lines from an unaffected first degree relative

ABSTRACT: A major barrier to research on Parkinson’s disease (PD) is inaccessibility of diseased tissue for study. One solution is to derive induced pluripotent stem cells (iPSCs) from patients with PD and differentiate them into neurons affected by disease. We created an iPSC model of PD caused by triplication of SNCA encoding α-synuclein. α-Synuclein dysfunction is common to all forms of PD, and SNCA triplication leads to fully penetrant familial PD with accelerated pathogenesis. After differentiation of iPSCs into neurons enriched for midbrain dopaminergic subtypes, those from the patient contain double α-synuclein protein compared to those from an unaffected relative, precisely recapitulating the cause of PD in these individuals. A measurable biomarker makes this model ideal for drug screening for compounds that reduce levels of α-synuclein, and for mechanistic experiments to study PD pathogenesis. This gene expression microarray study was carried out as part of the validation process for demonstrating that the generated iPSC lines are pluripotent. 5 samples were analysed: two clonal iPSC lines from each of two genotypes (four in total; AST denoting alpha-synuclein triplication and NAS denoting normal alpha-synuclein), a human embryonic stem cell line (SHEF4). All cultured in self-renewal conditions, mTeSR1

ORGANISM(S): Homo sapiens

SUBMITTER: Tilo Kunath 

PROVIDER: E-GEOD-30792 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

A major barrier to research on Parkinson's disease is inaccessibility of diseased tissue for study. One solution is to derive induced pluripotent stem cells from patients and differentiate them into neurons affected by disease. Triplication of SNCA, encoding α-synuclein, causes a fully penetrant, aggressive form of Parkinson's disease with dementia. α-Synuclein dysfunction is the critical pathogenic event in Parkinson's disease, multiple system atrophy and dementia with Lewy bodies. Here we prod  ...[more]

Similar Datasets

Transcriptomics Expression data from fibroblasts, iPSCs and neurons with four copies of SNCA, and equivalent cell lines from an unaffected first degree relative
2011-09-14 | E-GEOD-28365 | biostudies-arrayexpress
Transcriptomics SNP data from genomic DNA from a subject, fibroblasts, iPSCs and neurons with four copies of SNCA, and genomic DNA from an unaffected first degree relative and equivalent cell lines
2011-09-14 | E-GEOD-28366 | biostudies-arrayexpress
Genomics SNP data from genomic DNA from a subject, fibroblasts, iPSCs and neurons with four copies of SNCA, and genomic DNA from an unaffected first degree relative and equivalent cell lines
2011-09-15 | GSE28366 | GEO
Transcriptomics Expression data from Parkinson's iPSCs with four copies of SNCA, and equivalent cell lines from an unaffected first degree relative
2011-09-15 | GSE30792 | GEO
Transcriptomics Expression data from fibroblasts, iPSCs and neurons with four copies of SNCA, and equivalent cell lines from an unaffected first degree relative
2011-09-15 | GSE28365 | GEO
Transcriptomics RNA-seq of human midbrain organoid models of Parkinson's Disease
2021-08-13 | E-MTAB-7302 | biostudies-arrayexpress
Transcriptomics Single cell RNA sequencing data of SNCA triplication cortical organoids
2024-09-18 | GSE236002 | GEO
Transcriptomics Single nucleus RNA sequencing data of Lewy Body Dementia (LBD) brains
2024-09-18 | GSE235914 | GEO
Transcriptomics Single cell RNA sequencing analysis of midbrain organoids with SNCA gene triplication modeling key features of synuclienopathy
2021-11-02 | GSE186780 | GEO
Transcriptomics Synaptic decline precedes dopaminergic neuronal loss in human midbrain organoids harboring a triplication of the SNCA gene
2024-12-02 | GSE278265 | GEO